3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine

C136H173F7N42O4 — CID 158152575

IUPAC3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine
SMILESCN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccncc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)C(=O)NC(C)(C)C)CC2)c1C.Cn1nccc1-c1nnc(N2CCC(NCc3ccc(C(F)(F)F)cn3)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ccc(F)cc3C(F)(F)F)CC2)c2ccccc12
InChIInChI=1S/C24H22F4N6.C24H24F3N7.C23H31N7O.C22H30N8O.C22H33N7O.C21H33N7O/c1-33-21(8-11-29-33)22-17-4-2-3-5-18(17)23(32-31-22)34-12-9-16(10-13-34)30-20-7-6-15(25)14-19(20)24(26,27)28;1-33-21(8-11-30-33)22-19-4-2-3-5-20(19)23(32-31-22)34-12-9-17(10-13-34)29-15-18-7-6-16(14-28-18)24(25,26)27;1-23(2,3)25-22(31)28(4)16-11-14-30(15-12-16)21-18-9-7-6-8-17(18)20(26-27-21)19-10-13-24-29(19)5;1-22(2,3)25-21(31)28(4)15-8-12-30(13-9-15)20-17-14-23-10-6-16(17)19(26-27-20)18-7-11-24-29(18)5;1-22(2,3)24-21(30)27(4)15-10-13-29(14-11-15)20-17-8-6-7-16(17)19(25-26-20)18-9-12-23-28(18)5;1-14-15(2)19(25-24-18(14)17-8-11-22-27(17)7)28-12-9-16(10-13-28)26(6)20(29)23-21(3,4)5/h2-8,11,14,16,30H,9-10,12-13H2,1H3;2-8,11,14,17,29H,9-10,12-13,15H2,1H3;6-10,13,16H,11-12,14-15H2,1-5H3,(H,25,31);6-7,10-11,14-15H,8-9,12-13H2,1-5H3,(H,25,31);9,12,15H,6-8,10-11,13-14H2,1-5H3,(H,24,30);8,11,16H,9-10,12-13H2,1-7H3,(H,23,29)
InChIKeyFVHIDKSDBUJXJR-UHFFFAOYSA-N
MW2593.16 g/mol
LogP21.42
Rot. Bonds21

About 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine

3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine (PubChem CID 158152575) has the molecular formula C136H173F7N42O4 and a molecular weight of 2593.16 g/mol. Its IUPAC name is 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine.

Molecular Properties

Compound Name3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine
PubChem CID158152575
Molecular FormulaC136H173F7N42O4
Molecular Weight2593.16 g/mol
Exact Mass2591.45
IUPAC Name3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine
SMILESCN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccncc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)C(=O)NC(C)(C)C)CC2)c1C.Cn1nccc1-c1nnc(N2CCC(NCc3ccc(C(F)(F)F)cn3)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ccc(F)cc3C(F)(F)F)CC2)c2ccccc12
InChIInChI=1S/C24H22F4N6.C24H24F3N7.C23H31N7O.C22H30N8O.C22H33N7O.C21H33N7O/c1-33-21(8-11-29-33)22-17-4-2-3-5-18(17)23(32-31-22)34-12-9-16(10-13-34)30-20-7-6-15(25)14-19(20)24(26,27)28;1-33-21(8-11-30-33)22-19-4-2-3-5-20(19)23(32-31-22)34-12-9-17(10-13-34)29-15-18-7-6-16(14-28-18)24(25,26)27;1-23(2,3)25-22(31)28(4)16-11-14-30(15-12-16)21-18-9-7-6-8-17(18)20(26-27-21)19-10-13-24-29(19)5;1-22(2,3)25-21(31)28(4)15-8-12-30(13-9-15)20-17-14-23-10-6-16(17)19(26-27-20)18-7-11-24-29(18)5;1-22(2,3)24-21(30)27(4)15-10-13-29(14-11-15)20-17-8-6-7-16(17)19(25-26-20)18-9-12-23-28(18)5;1-14-15(2)19(25-24-18(14)17-8-11-22-27(17)7)28-12-9-16(10-13-28)26(6)20(29)23-21(3,4)5/h2-8,11,14,16,30H,9-10,12-13H2,1H3;2-8,11,14,17,29H,9-10,12-13,15H2,1H3;6-10,13,16H,11-12,14-15H2,1-5H3,(H,25,31);6-7,10-11,14-15H,8-9,12-13H2,1-5H3,(H,25,31);9,12,15H,6-8,10-11,13-14H2,1-5H3,(H,24,30);8,11,16H,9-10,12-13H2,1-7H3,(H,23,29)
InChIKeyFVHIDKSDBUJXJR-UHFFFAOYSA-N
XLogP21.42
TPSA460.24 Ų
H-Bond Donors6
H-Bond Acceptors38
Rotatable Bonds21
Heavy Atoms189
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002593.16
LogP ≤ 521.42
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1038

Analyze 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine?
The IUPAC name of 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine (CID 158152575) is 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine.
What is the SMILES notation for 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine?
The canonical SMILES for 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine is CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccncc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)C(=O)NC(C)(C)C)CC2)c1C.Cn1nccc1-c1nnc(N2CCC(NCc3ccc(C(F)(F)F)cn3)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ccc(F)cc3C(F)(F)F)CC2)c2ccccc12.
What is the InChIKey of 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine?
The InChIKey is FVHIDKSDBUJXJR-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22F4N6.C24H24F3N7.C23H31N7O.C22H30N8O.C22H33N7O.C21H33N7O/c1-33-21(8-11-29-33)22-17-4-2-3-5-18(17)23(32-31-22)34-12-9-16(10-13-34)30-20-7-6-15(25)14-19(20)24(26,27)28;1-33-21(8-11-30-33)22-19-4-2-3-5-20(19)23(32-31-22)34-12-9-17(10-13-34)29-15-18-7-6-16(14-28-18)24(25,26)27;1-23(2,3)25-22(31)28(4)16-11-14-30(15-12-16)21-18-9-7-6-8-17(18)20(26-27-21)19-10-13-24-29(19)5;1-22(2,3)25-21(31)28(4)15-8-12-30(13-9-15)20-17-14-23-10-6-16(17)19(26-27-20)18-7-11-24-29(18)5;1-22(2,3)24-21(30)27(4)15-10-13-29(14-11-15)20-17-8-6-7-16(17)19(25-26-20)18-9-12-23-28(18)5;1-14-15(2)19(25-24-18(14)17-8-11-22-27(17)7)28-12-9-16(10-13-28)26(6)20(29)23-21(3,4)5/h2-8,11,14,16,30H,9-10,12-13H2,1H3;2-8,11,14,17,29H,9-10,12-13,15H2,1H3;6-10,13,16H,11-12,14-15H2,1-5H3,(H,25,31);6-7,10-11,14-15H,8-9,12-13H2,1-5H3,(H,25,31);9,12,15H,6-8,10-11,13-14H2,1-5H3,(H,24,30);8,11,16H,9-10,12-13H2,1-7H3,(H,23,29).
What are the key properties of 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine?
3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine has a molecular weight of 2593.16 g/mol, XLogP of 21.42, 21 rotatable bonds, 6 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine is sourced from PubChem (CID 158152575), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).